Interferon-alpha2a is sufficient for promoting dendritic cell immunogenicity.


Type I interferons (IFNs) are widely used therapeutically. IFN-alpha2a in particular is used as an antiviral agent, but its immunomodulatory properties are poorly understood. Dendritic cells (DCs) are the only antigen-presenting cells able to prime naive T cells and therefore play a crucial role in initiating the adaptive phase of the immune response. We… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.